T1	Participants 28 134	ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH):
T2	Participants 193 274	patients with ventricular tachycardia (VT) and a history of myocardial infarction
T3	Participants 628 811	The Ventricular Tachycardia Ablation in Coronary Heart Disease (VTACH) study was a prospective, open, randomised controlled trial, undertaken in 16 centres in four European countries.
T4	Participants 812 984	Patients aged 18-80 years were eligible for enrolment if they had stable VT, previous myocardial infarction, and reduced left-ventricular ejection fraction (LVEF; <or=50%).
T5	Participants 985 1036	110 patients were randomly allocated in a 1:1 ratio
T6	Participants 1521 1614	107 patients were included in the ITT population (ablation group, n=52; control group, n=55).
T7	Participants 2456 2536	Nine patients died during the study (ablation group, five; control group, four).
T8	Participants 2657 2731	patients with stable VT, previous myocardial infarction, and reduced LVEF.
